Grantee Research Project Results
| ** The following contact information is the latest on record and may not be up to date. | |
|---|---|
| Name: | Paul E. Morrow |
| Location:v | University of Rochester |
| E-mail: | morrowpe@aol.com |
| Phone: | (585) 442-7484 |
| Address: | University of Rochester |
| City: | Rochester |
| State: | NY |
| Zip Code: | 14627 |
| Grant Number | Project Title | Abstract Type | Project Period | |
|---|---|---|---|---|
| Co-Investigator: | ||||
| R827354 | Ultrafine Particles: Characterization, Health Effects and Pathophysiological Mechanisms | Centers | June 1, 1999 through May 31, 2005 | |
| R827354C003 | Clinical Studies of Ultrafine Particle Exposure in Susceptible Human Subjects | Centers | June 1, 1999 through May 31, 2005 | |
| R827354C004 | Animal Models: Dosimetry, and Pulmonary and Cardiovascular Events | Centers | June 1, 1999 through May 31, 2005 | |
| R827354C005 | Ultrafine Particle Cell Interactions: Molecular Mechanisms Leading to Altered Gene Expression | Centers | June 1, 1999 through May 31, 2005 | |
| R828112C043 | Human Responses to Nitrogen Dioxide | Centers | April 1, 2000 through March 31, 2005 | |
| R828112C078 | Effects of Ozone on Pulmonary Function and Airway Inflammation in Normal and Potentially Sensitive Human Subjects | Centers | April 1, 2000 through March 31, 2005 | |
The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.